tiprankstipranks
Advertisement
Advertisement

DTIL Stock Latest News

Precision BioSciences announces results from low-dose cohort of ECUR-506
The FlyPrecision BioSciences announces results from low-dose cohort of ECUR-506
3d ago
DTIL
Precision BioSciences presents new preclinical data on Pbgene-DMD program
PremiumThe Fly
Precision BioSciences presents new preclinical data on Pbgene-DMD program
7d ago
DTIL
Precision BioSciences sees cash runway through 2028
PremiumThe Fly
Precision BioSciences sees cash runway through 2028
16d ago
DTIL
Precision BioSciences reports Q1 EPS (75c) vs. ($2.21) last year
PremiumThe Fly
Precision BioSciences reports Q1 EPS (75c) vs. ($2.21) last year
16d ago
DTIL
Precision BioSciences activates first clinical trial site for PBGENE-DMD
PremiumThe Fly
Precision BioSciences activates first clinical trial site for PBGENE-DMD
22d ago
DTIL
Precision BioSciences announces oral presentation at ASGCT 2026
PremiumThe FlyPrecision BioSciences announces oral presentation at ASGCT 2026
23d ago
DTIL
Precision BioSciences announces grant of inducement awards
Premium
The Fly
Precision BioSciences announces grant of inducement awards
27d ago
DTIL
Precision Bio’s 15-Year HBV Follow-Up Study: What Investors Should Know
Premium
Company Announcements
Precision Bio’s 15-Year HBV Follow-Up Study: What Investors Should Know
28d ago
DTIL
Precision BioSciences assumed with a Buy at JonesResearch
PremiumThe Fly
Precision BioSciences assumed with a Buy at JonesResearch
1M ago
DTIL
Precision BioSciences receives CTA approval to expand Eliminate-B trial
PremiumThe Fly
Precision BioSciences receives CTA approval to expand Eliminate-B trial
1M ago
DTIL
Precision BioSciences Highlights PBGENE-DMD Program and Trial
PremiumCompany Announcements
Precision BioSciences Highlights PBGENE-DMD Program and Trial
2M ago
8K
DTIL
Precision BioSciences Advances PBGENE-DMD Trial, Putting New Focus on Duchenne Gene Therapy
PremiumCompany Announcements
Precision BioSciences Advances PBGENE-DMD Trial, Putting New Focus on Duchenne Gene Therapy
2M ago
DTIL
Precision BioSciences reports Q4 EPS $1.05, consensus (64c)
PremiumThe FlyPrecision BioSciences reports Q4 EPS $1.05, consensus (64c)
2M ago
DTIL
Precision receives two notices of allowance from USPTO for PBGENE-HBV
Premium
The Fly
Precision receives two notices of allowance from USPTO for PBGENE-HBV
2M ago
DTIL
Precision BioSciences presents new PBGENE-DMD data at conference
Premium
The Fly
Precision BioSciences presents new PBGENE-DMD data at conference
2M ago
DTIL
Is DTIL a Buy, Before Earnings?
PremiumPre-Earnings
Is DTIL a Buy, Before Earnings?
2M ago
DTIL
Precision BioSciences announces fast track designation for PBGENE-DMD
PremiumThe Fly
Precision BioSciences announces fast track designation for PBGENE-DMD
2M ago
DTIL
Precision to get $7.5M in proceeds from TG Therapeutics for azer-cel milestone
PremiumThe Fly
Precision to get $7.5M in proceeds from TG Therapeutics for azer-cel milestone
3M ago
DTIL
TGTX
Precision BioSciences Highlights 2026 Gene Editing Priorities
PremiumCompany Announcements
Precision BioSciences Highlights 2026 Gene Editing Priorities
4M ago
8K
DTIL
Precision BioSciences: Promising Advancements in Genetic Medicine with Key Data Updates Anticipated by 2026
PremiumRatingsPrecision BioSciences: Promising Advancements in Genetic Medicine with Key Data Updates Anticipated by 2026
5M ago
DTIL
Precision BioSciences’ Promising Gene Editing Advancements Justify Buy Rating
Premium
Ratings
Precision BioSciences’ Promising Gene Editing Advancements Justify Buy Rating
6M ago
DTIL
Precision BioSciences Announces $70M Stock Offering
Premium
Company Announcements
Precision BioSciences Announces $70M Stock Offering
6M ago
8K
DTIL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >